PRLD
Prelude Therapeutics Inc
3.70$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -193.8% | – | – | |
| – | +18.6% | +28.7% | +6.1% | -10.4% | +20.7% | -11.0% | -0.5% | -1.8% | -32.9% | +37.2% | -9.7% | – | |
| – | -12.0% | -6.2% | +9.9% | -2.8% | -36.3% | +1.5% | -0.5% | -36.5% | -23.9% | +8.5% | +1.4% | – | |
| – | – | -240.1% | – | -115.4% | – | -260.4% | – | -448.0% | – | -136.9% | – | – | |
| – | +91.0% | -74.4% | +24.2% | -82.5% | -15.9% | -11.3% | -57.4% | -100.0% | – | – | – | – | |
| – | -48.6% | +303.6% | -16.3% | -58.9% | +106.1% | +181.2% | -81.5% | +248.0% | -250.5% | – | -870.7% | – | |
| – | -93.8% | +1,500.0% | +12.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2.0% | +2.6% | -65.8% | -100.0% | – | – | – | – | |
| – | +28,578.4% | -100.1% | – | -322.0% | -74.0% | +370.6% | – | -113.5% | – | -101.3% | – | – | |
| – | – | -106.2% | – | -634.9% | – | +1,974.3% | -152.2% | – | -158.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -193.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.